Clinical Trials in Al Ain City, Abu Dhabi Emirate
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled295 locationsNCT06926868
Recruiting
Phase 1Phase 2
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
Advanced Solid TumorNSCLC
Ellipses Pharma265 enrolled40 locationsNCT05443126